Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115, USA.
Trends Microbiol. 2011 Jul;19(7):304-6. doi: 10.1016/j.tim.2011.03.003. Epub 2011 Mar 31.
Nearly 12 years after promising results suggested that antibiofilm agents might be developed into novel therapeutics, there are no such products on the market. In our opinion, the reasons for this have been predominantly economic. Recent developments, however, suggest that there could still be emerging opportunities for the developments of such products.
近 12 年前，有研究结果表明，抗生物膜剂可能被开发成新型疗法，此后便再无相关进展。在我们看来，这主要是出于经济方面的考虑。然而，最近的一些发展表明，此类产品的开发仍可能会出现新的机遇。
